المؤلفون: Leray A; Nantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France., Lalys PA; Nantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France., Varin J; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Bouzelha M; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Bourdon A; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Alvarez-Dorta D; Capacités, 26 Bd Vincent Gâche, 44200 Nantes, France., Pavageau K; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Depienne S; Nantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France., Marchand M; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Mellet A; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Demilly J; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Ducloyer JB; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Girard T; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Fraysse B; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Ledevin M; INRAE, Oniris, PanTher, APEX, F-44307 Nantes, France., Guilbaud M; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Gouin SG; Nantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France., Ayuso E; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Adjali O; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Larcher T; INRAE, Oniris, PanTher, APEX, F-44307 Nantes, France., Cronin T; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Le Guiner C; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France., Deniaud D; Nantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France. Electronic address: david.deniaud@univ-nantes.fr., Mével M; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000 Nantes, France. Electronic address: mathieu.mevel@univ-nantes.fr.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Feb; Vol. 171, pp. 116148. Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Dependovirus* , Genetic Therapy*, Animals ; Transduction, Genetic ; Tyrosine/genetics ; Liver ; Retina ; Capsid Proteins/genetics ; Genetic Vectors ; Gene Transfer Techniques

المؤلفون: Mével M; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Pichard V; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Bouzelha M; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Alvarez-Dorta D; Nantes Université, CNRS, CEISAM UMR 6230, 44000 Nantes, France., Lalys PA; Nantes Université, CNRS, CEISAM UMR 6230, 44000 Nantes, France., Provost N; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Allais M; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Mendes A; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Landagaray E; Nantes Université, CNRS, CEISAM UMR 6230, 44000 Nantes, France., Ducloyer JB; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Toublanc E; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Galy A; Coave Therapeutics (formerly, Horama), 75012 Paris, France., Brument N; Coave Therapeutics (formerly, Horama), 75012 Paris, France., Lefevre GM; Coave Therapeutics (formerly, Horama), 75012 Paris, France., Gouin SG; Nantes Université, CNRS, CEISAM UMR 6230, 44000 Nantes, France., Isiegas C; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Le Meur G; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Cronin T; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Le Guiner C; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Weber M; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Moullier P; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Ayuso E; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France., Deniaud D; Nantes Université, CNRS, CEISAM UMR 6230, 44000 Nantes, France., Adjali O; Nantes Université, CHU de Nantes, INSERM UMR 1089, TaRGeT-Translational Research in Gene Therapy Laboratory, 44200 Nantes, France.

المصدر: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Jan 17; Vol. 32 (1), pp. 101187. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE

المؤلفون: Depienne S; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France., Bouzelha M; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000, Nantes, France., Courtois E; Nantes Université, CNRS, US2B, UMR 6286, F-44000, Nantes, France., Pavageau K; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000, Nantes, France., Lalys PA; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France., Marchand M; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France., Alvarez-Dorta D; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France.; Capacités, 16 rue des marchandises, 44200, Nantes, France., Nedellec S; Nantes Université, CHU Nantes, CNRS, Inserm, BioCore, US16, SFR Bonamy, Nantes, France., Marín-Fernández L; Nantes Université, CNRS, US2B, UMR 6286, F-44000, Nantes, France., Grandjean C; Nantes Université, CNRS, US2B, UMR 6286, F-44000, Nantes, France., Boujtita M; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France., Deniaud D; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France., Mével M; Nantes Université, TaRGeT, Translational Research for Gene Therapies, CHU Nantes, INSERM, UMR 1089, F-44000, Nantes, France. mathieu.mevel@univ-nantes.fr., Gouin SG; Nantes Université, CNRS, CEISAM UMR 6230, F-44000, Nantes, France. sebastien.gouin@univ-nantes.fr.

المصدر: Nature communications [Nat Commun] 2023 Aug 23; Vol. 14 (1), pp. 5122. Date of Electronic Publication: 2023 Aug 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Bacteria* , Dependovirus*/genetics, Humans ; Electrochemistry ; HEK293 Cells ; Cell Membrane ; Escherichia coli

المؤلفون: Dussouy C; Université de Nantes, CNRS, CEISAM UMR, 6230, F-44000, Nantes, France. sebastien.gouin@univ-nantes.fr., Lalys PA, Cabanettes A, Lehot V, Deniaud D, Gillon E, Balloy V, Varrot A, Gouin SG

المصدر: Organic & biomolecular chemistry [Org Biomol Chem] 2021 Apr 14; Vol. 19 (14), pp. 3234-3240. Date of Electronic Publication: 2021 Mar 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101154995 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0539 (Electronic) Linking ISSN: 14770520 NLM ISO Abbreviation: Org Biomol Chem Subsets: MEDLINE

مواضيع طبية MeSH: Aspergillus fumigatus/*chemistry , Fucose/*pharmacology , Lectins/*antagonists & inhibitors , Sulfhydryl Compounds/*pharmacology, Aspergillus fumigatus/metabolism ; Aspergillus fumigatus/pathogenicity ; Dose-Response Relationship, Drug ; Drug Design ; Fucose/chemical synthesis ; Fucose/chemistry ; Lectins/metabolism ; Models, Molecular ; Molecular Structure ; Structure-Activity Relationship ; Sulfhydryl Compounds/chemical synthesis ; Sulfhydryl Compounds/chemistry